The efficacy and safety of qiliqiangxin according to baseline ejection fraction in patients with heart failure and reduced ejection fraction in QUEST

Authors

Institutions

Publication Details

Journal
European Journal of Heart Failure
Published
2026-01-06
DOI
https://doi.org/10.1093/ejhf/xuaf017
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The efficacy and safety of qiliqiangxin according to baseline ejection fraction in patients with heart failure and reduced ejection fraction in QUEST

Bouchra Lamia, Xinli Li, Li Qp, Li Shen et al.
European Journal of Heart Failure
Heart Failure Treatment and Management
article

The efficacy and safety of qiliqiangxin according to baseline ejection fraction in patients with heart failure and reduced ejection fraction in QUEST

Bouchra Lamia, Xinli Li, Li Qp, Li Shen, Wenming Yao, Xuetao Zhu, Mark C Petrie, John J. V. McMurray, Yue Zhang, Haifeng Zhang, Ying Yang, Liwen Shen, Pardeep S Jhund
article en

Abstract

No abstract available for this paper.
European Journal of Heart Failure
Hangzhou Normal University (CN), British Heart Foundation (GB), National University Heart Centre Singapore (SG), National University Hospital (SG), National Heart Centre Singapore (SG), University of Glasgow (GB), Nanjing Medical University (CN)
Good health and well-being
Openalex Percentile: Top 91%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.